InsideScientific | A Scientist.com Company’s Post

Our new blog shares insights into how biopharma companies are effectively engaging with community oncologists in our Oncology Provider Extended Network (OPEN). Learn more: https://lnkd.in/gchKN7-E . #biopharma #oncology

Our new blog shares insights into how biopharma companies are effectively engaging with community oncologists in our Oncology Provider Extended Network (OPEN). Learn more: https://lnkd.in/gchKN7-E . #biopharma #oncology

Reminder to all of you #ESMO24 attendees to speak to one of our experts from WEP Clinical to discuss all things #drugdevelopment, #expandedaccess, #posttrialaccess, #commercialization and more! Prashant Desai Simon Clayton Ana Paula Tediosi #clinicaltrials, #clinicaldevelopment #oncology

Project Optimus is revolutionizing early oncology trials, aiming to ensure more effective and safer cancer drugs and improve patients' quality of life. Parexel experts, including Amy McKee, Sinan Sarac, and Pengfei Song have identified three strategies to help sponsors overcome challenges in achieving dose-optimization requirements. Here’s what we know works: 1️⃣ Design an integrated first-in-human study 2️⃣ Reach an agreement with the FDA at each step 3️⃣ Challenge guidelines with a compelling rationale Let me know your thoughts below, and read more in our New Medicines, Novel Insights report! https://lnkd.in/eUt4G8xC #ProjectOptimus #Oncology #NovelInsights

Download our latest insight brief with Gerhard du Toit, Global Oncology Head at IQVIA Biotech, and learn how global oncology trends are impacting clinical trial strategy in early phase oncology, platform design trials, and diversity planning. Download now. https://bit.ly/4bYb5tA #oncology #clinicaltrials #earlyphaseoncology

Choosing the right sites for oncology clinical trials in Europe can be complex and time-consuming. European oncology site networks streamline this process by offering pre-vetted, high-performing sites, speeding up study start-up and improving recruitment rates. Learn how to partner with these networks to accelerate your trial’s success: https://hubs.ly/Q02W6S3d0 #oncology #clinicalresearch #siteselection

Missed our webinar? No worries—we’ve got you covered! If you couldn’t join us for "Tackling Complexity in Oncology Biomarker Interpretation with CGW Plus," you can now watch the full recording! Discover how CGW Plus can streamline your workflow and simplify biomarker interpretation in oncology. Whether you’re looking to improve accuracy, and efficiency, or just curious to learn more, this webinar offers valuable insights you won’t want to miss! Check out the recording here: https://lnkd.in/gw2bM9nJ #EraofVelsera #Oncology #BiomarkerInterpretation #Webinar #NGS #MolecularDiagnostics

Did you know that in 2023, Inizio worked on 148 oncology assets? With 91 of these being small molecule oncology assets. By leveraging technology and the latest medical and scientific data, along with HCP and patient insights, Inizio helps to support actionable outcomes for you. Want to learn more about our oncology expertise? Visit booth 37157 at the ASCO® Annual Meeting in Chicago this weekend. https://lnkd.in/ggTHcREU #ASCO24 #oncology

As #ESMO2024 draws to a close, it's clear that even as #oncology enters the second half of the second decade of being the world's most valuable therapy area, the innovative pipeline for cancer therapies remains exceptionally strong, with exciting new MoAs emerging in bispecifics, anti-body-drug conjugates, and radioligands. However, pipeline promise needs to translate to commercial reality for success. Find out more in our exciting webinar on September 26th, where we'll be talking the oncology pipe and oncology #LaunchExcellence - register now!

Are you ready to accelerate your #oncology trial and get your product to market? Over 12 months, IQVIA successfully supported 11 oncology market approvals. If you'd like to learn how we can help support your oncology trial, visit our webpage: https://bit.ly/3zprf1f #oncology #clinicaltrials